Skip to content

Hims & Hers Health

US · HIMS #1813 by market cap Listed 1970
14.60 -1.42 -8.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 10 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.8 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
69.32% +1.76pp
Institutions
590 -10
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund49.39%
Individual/Insider8.32%
Hedge Fund7.84%
Public Company7.81%
Private Company1.41%
Government Pension Fund1.38%
VC/PE Fund0.62%
Family Office/Trust0.44%
Insurance Company0.33%
Other22.45%

Top holders as of 2026-09-30

BlackRock 12.69% · 29.74M sh
Andrew Dudum 7.09% · 16.61M sh
Vanguard Portfolio Management, LLC 4.44% · 10.41M sh
Vanguard Capital Management, LLC 4.06% · 9.53M sh
State Street Global Advisors 3.52% · 8.24M sh
Morgan Stanley 2.66% · 6.24M sh
Morgan Stanley Investment Management Inc. 2.66% · 6.24M sh
Divisadero Street Capital Management, LP 2.56% · 6.01M sh
Geode Capital Management, LLC 2.40% · 5.63M sh
The Goldman Sachs Group, Inc. 1.90% · 4.43M sh
FMR 1.85% · 4.32M sh
UBS Asset Management 2.21% · 5.18M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 25 sells

NameRoleStake
Andrew Dudum Chairperson & CEO 7.09%
Melissa Baird Former Chief Operating Officer 0.34%
Mike Chi Chief Operating Officer 0.19%
Soleil Boughton Chief Legal Officer 0.13%
Oluyemi Okupe Chief Financial Officer 0.10%
David Wells Lead Independent Director 0.10%
Patrick Carroll Global Chief Medical Officer 0.08%
Mohamed ElShenawy Chief Technology Officer 0.08%
Christopher Payne Independent Director 0.06%
Andrea Perez Garcia Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-10 David Wells Lead Independent Director Other Derivative Acquisition +1,051 --
2026-11-10 Christopher Payne Independent Director Other Derivative Acquisition +810 --
2026-11-10 Andrew Huberman Director Other Derivative Acquisition +19,301 --
2026-11-10 Jonathan Franklin Chief Accounting Officer & Principal Accounting Officer Other Derivative Acquisition +102,774 --
2026-10-27 Soleil Boughton Chief Legal Officer Automatic Disposition -3,462 $27.60
2026-10-27 Soleil Boughton Chief Legal Officer Intent to Sell (Form 144) -3,462 $27.60
2026-10-13 Soleil Boughton Chief Legal Officer Automatic Disposition -3,461 $29.06
2026-09-30 Oluyemi Okupe Chief Financial Officer Automatic Disposition -2,000 $29.70
2026-09-29 Soleil Boughton Chief Legal Officer Automatic Disposition -3,461 $29.17
2026-09-21 Oluyemi Okupe Chief Financial Officer Automatic Disposition -15,277 $29.95
2026-09-21 Oluyemi Okupe Chief Financial Officer Derivative Exercise and Sale -14,000 $5.01–29.95
2026-09-16 Oluyemi Okupe Chief Financial Officer Automatic Disposition -12,313 $28.82
2026-09-15 Soleil Boughton Chief Legal Officer Automatic Disposition -6,236 $27.86
2026-09-14 Mike Chi Chief Operating Officer Automatic Disposition -14,027 $28.39
2026-09-14 Mohamed ElShenawy Chief Technology Officer Automatic Disposition -7,954 $28.39
2026-09-01 Soleil Boughton Chief Legal Officer Automatic Disposition -3,458 $28.33
2026-08-26 Andrew Dudum Chairperson & CEO Other Disposition -1,440,855 --
2026-08-18 Soleil Boughton Chief Legal Officer Automatic Disposition -25,111 $27.55
2026-08-18 Oluyemi Okupe Chief Financial Officer Derivative Exercise and Sale -4,938 $5.01–29.99
2026-08-17 Deborah Autor Chief Policy Officer & Director Automatic Disposition -16,773 $27.85

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Hims & Hers Health discussion 0 comments

Add a comment